Michael Roller - Bioquell plc Insider |
| Bioquell plc -- USA Stock | USD 3.50 0.00 0.00% |
Group Finance Director, Director
Mr. Michael R. D. Roller was appointed as Group Finance Director, Executive Director of the Comapny effective March 18, 2014. He Joined the Board in March 2014. He has previously been Finance Director of a number of quoted companies, most recently Corin Group PLC, has significant experience within the Life Sciences sector and is a non executive director of Filtronic plc. He qualified as an accountant with KPMG.
Age: 51 Director Since 2014
44 1264 835 900 http://www.bioquellplc.com
Management Efficiency
The company has return on total asset (ROA) of 5.32 % which means that it generated profit of $5.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.16 % meaning that it generated $5.16 on every $100 dollars invested by stockholders.Similar Executives
| Showing few of many executives | DIRECTOR Since | |
| Jesus Varela | Megaworld Corporation | 2016 |
| Charles Scharf | Microsoft Corporation | 2014 |
| Roger Ferguson | Alphabet | 2016 |
| Janis Lomax | HSBC Holdings plc | 2015 |
| Diane Greene | Alphabet | 2015 |
| Lord Weardale | HSBC Holdings plc | 2013 |
| Henri Castries | HSBC Holdings plc | 2016 |
| Phillip Ameen | HSBC Holdings plc | 2015 |
| Rona Fairhead | HSBC Holdings plc | 2004 |
| MayLung Cha | HSBC Holdings plc | 2011 |
| Mason Morfit | Microsoft Corporation | N/A |
| Robert Iger | Apple | 2011 |
| Roberto Guevara | Megaworld Corporation | 2001 |
| James Bell | Apple | 2015 |
| John Stanton | Microsoft Corporation | 2014 |
| John Hennessy | Alphabet | 2018 |
| Hugh Johnston | Microsoft Corporation | 2017 |
| AI Gore | Apple | 2003 |
| Charles Noski | Microsoft Corporation | 2003 |
| Jonathan Symonds | HSBC Holdings plc | 2017 |
| Albert Gore | Apple | 2003 |
Entity Summary
Bioquell PLC designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc is traded on OTC Market in USA.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 200 people.Bioquell plc Leadership Team
| Ian Johnson, Chairman | |
| Nigel Keen, Chairman | |
| Nicholas Adams, Director | |
| Christopher Mills, Director | |
| Anthony Bourne, Director | |
| Georgina Pope, Executive | |
| Michael Roller, Director | |
| Ian Carruthers, Director | |
| Simon Constantine, Director |
Stock Performance Indicators
| Shares Outstanding | 22.25 M |
BATS Exchange Efficient Frontier
Diversify in USA Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify PortfoliosCheck also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.